Oculis

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Jul 7, 2026

Recruiting

A Phase 2b/3, Double-masked, Randomized, Vehicle-controlled, Multicenter Study Evaluating Licaminlimab in Dry Eye Disease Patients With a Specific TNFR1 Genotype

Jul 2, 2026

Recruiting

A Randomized, Double-masked, Placebo-controlled Study Assessing the Efficacy and Safety of Privosegtor (OCS-05) in Patients With Optic Neuritis (ON)

Earlier

Mar 15, 2024TrialA Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)

Dec 18, 2023TrialStudy Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery

Nov 29, 2023TrialSafety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease

Jun 24, 2022TrialA Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Oct 19, 2021TrialA Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)

Feb 10, 2021TrialOCS-05 in Patients With Optic Neuritis

2 more events

Sep 27, 2019TrialOCS-01 in Treating Inflammation and Pain in Post-cataract Patients

Sep 18, 2017TrialEfficacy and Safety of Dexamethasone Nanoparticles Eye Drops in Diabetic Macular Edema

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)